Dudediligence.

Cingulate Inc

CINGNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$4.1MSep ’24−$6.2MDec ’24−$3.9MMar ’25−$5.0MJun ’25−$7.3MSep ’25−$6.3MDec ’25−$9.3MMar ’26−$5.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$20.7M−$17.5M−$22.8M−$15.6M−$19.9M
Net income−$20.7M−$17.7M−$23.5M−$16.6M−$22.4M
Operating cash flow−$10.4M−$15.9M−$15.0M−$18.5M−$17.2M
Free cash flow−$11.2M−$16.0M−$15.3M−$18.7M−$17.4M
Cash$16.5M$5.4M$52,416$12.2M$11.0M
Shares outstanding11.3M602.6K97.3K3.4M7.3M